Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
Madigan L. Bedard, Xi‐Ping Huang, J. G. Murray, et al.
Addiction Neuroscience (2024) Vol. 11, pp. 100155-100155
Open Access | Times Cited: 12
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data
W. David Bradford, Mary Figgatt, Karen S. Scott, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs
Jeanette M. Bowles, Elizabeth Copulsky, Megan K. Reed
International Journal of Drug Policy (2024) Vol. 125, pp. 104338-104338
Closed Access | Times Cited: 10
Xylazine-Associated Wounds and Related Health Concerns Among People Who Use Drugs: Reports From Front-Line Health Workers in 7 US States
Jennifer Carroll
Substance Use & Addiction Journal (2024) Vol. 45, Iss. 2, pp. 222-231
Closed Access | Times Cited: 6
Managing xylazine-involved overdoses in a community harm reduction setting: lessons from Tijuana, Mexico
Lilia Pacheco Bufanda, Alejando González Montoya, B Carrillo, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat among US Adults
Olivia K. Golan, Weiwei Liu, Bruce G. Taylor
Journal of Addiction Medicine (2025)
Closed Access
“We can't change that while they're in the hospital”: Unveiling the manifestations of infrastructural violence and wound care for people who inject drugs
Suzanne J Block, Laura Nicole Sisson, Yasemin Taban, et al.
International Journal of Drug Policy (2025) Vol. 137, pp. 104716-104716
Closed Access
Real Time, On-Site Drug Checking in Low-Threshold Housing Communities
Charlie Summers, Joseph Silcox, Sofia Zaragoza, et al.
(2025)
Closed Access
Detecting Xylazine
Katie Troike, A. J. McShane
Clinics in Laboratory Medicine (2025)
Closed Access
Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore
Danielle German, Becky L. Genberg, Olivia K. Sugarman, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study
Ju Nyeong Park, Rachel Serafinski, Merci Ujeneza, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 11, pp. 100247-100247
Open Access | Times Cited: 4
Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical Protocols
Margaret Shang, Ilana Hull, Jane M. Liebschutz, et al.
Substance Use & Addiction Journal (2025)
Closed Access
Xylazine Poisoning in Clinical and Forensic Practice: Analysis Method, Characteristics, Mechanism and Future Challenges
Tingting Mai, Youyou Zhang, Shuquan Zhao
Toxics (2023) Vol. 11, Iss. 12, pp. 1012-1012
Open Access | Times Cited: 7
Classics in Chemical Neuroscience: Xylazine
Gavin R. Hoffman, Chetan Giduturi, Nicholas J. Cordaro, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2091-2098
Closed Access | Times Cited: 2
Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study
Ian David Aronson, Mary-Andrée Ardouin-Guerrier, Juan Esteban Baus, et al.
JMIR Formative Research (2024) Vol. 8, pp. e56755-e56755
Open Access | Times Cited: 2
Drug use practices and wound care experiences in the age of xylazine adulteration
Raagini Jawa, Samia Ismail, Margaret Shang, et al.
Drug and Alcohol Dependence (2024) Vol. 263, pp. 112390-112390
Open Access | Times Cited: 2
Network pharmacology of xylazine to understand Its health consequences and develop mechanistic based remediations
Arun Kumar
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Implications of xylazine exposure in pregnancy: a narrative review
Ilana Hull, Raagini Jawa, Margaret Shang, et al.
Journal of Addictive Diseases (2024), pp. 1-8
Closed Access | Times Cited: 1
A call for compassionate opioid overdose response
Erin Russell, Mary Hawk, Joanne Neale, et al.
International Journal of Drug Policy (2024) Vol. 133, pp. 104587-104587
Open Access | Times Cited: 1
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023–2024
Nichole L. Michaels, Saroj Bista, Ashley Short Mejia, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Xylazine’s Impacts on the Community in Philadelphia: Perspectives of People Who Use Opioids and Harm Reduction Workers
Megan K. Reed, Tracy Esteves Camacho, Rebecca E. Olson, et al.
Substance Use & Misuse (2024), pp. 1-8
Closed Access | Times Cited: 1
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Trends and Adverse Outcomes of Xylazine Misuse: A Digital Surveillance Study
Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Seongjin Kim
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xylazine Awareness, Desire, Use and Exposure: Preliminary Findings from the Rhode Island CUTS Drug Checking Cohort
Ju Nyeong Park, Rachel Serafinski, Merci Ujeneza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
New Choking Epidemic Trends in Psychoactive Drugs: The Zombifying Combination of Fentanyl and Xylazine Cause Overdoses and Little Hope in Rehabilitation
Ricardo Jorge Dinis‐Oliveira
Psychoactives (2024) Vol. 3, Iss. 1, pp. 132-136
Open Access
Page 1 - Next Page

Scroll to top